GWM
TECH icon

Gibbs Wealth Management’s Bio-Techne TECH Stock Holding History

Gibbs Wealth Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Buy
+8,131
New +$488K 0.06% 335

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Gibbs Wealth Management's TECH Position: Q1 2026 in Review

Gibbs Wealth Management opened a new position in Bio-Techne (TECH) in Q1 2026: 8,131 shares worth $425K. The stake represents 0.06% of the portfolio and ranks #335 among its holdings.

584 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Gibbs Wealth Management held 8,131 shares of Bio-Techne worth $425K as of Q1 2026.
  • Bio-Techne was a new Gibbs Wealth Management position in Q1 2026.
  • Bio-Techne made up 0.06% of Gibbs Wealth Management's portfolio in Q1 2026, its #335 holding.
  • 584 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Gibbs Wealth Management's 13F filing for Q1 2026, filed 13 May 2026.